CD274 and melanoma: In the human setting, a study reported enhanced circulating TGF-β+PD-L1+ B cells and TGF-β+:TNF-α+ B cell ratios and lower pro-inflammatory TNF-α+ B cells and IFN-γ+:IL-4+ B cell ratios as a feature of melanoma [46].